186 related articles for article (PubMed ID: 12229247)
1. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
Arkenau HT; Widjaja A
Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
[TBL] [Abstract][Full Text] [Related]
2. Severe intrahepatic cholestasis and rapidly progressive renal failure in a patient with immunocyte-related amyloidosis.
Skander MP; Harry DS; Lee FI
J Clin Gastroenterol; 1987 Apr; 9(2):219-22. PubMed ID: 3106463
[TBL] [Abstract][Full Text] [Related]
3. [An unusual cause of hepatorenal symptoms].
Frank H; Krammer M; Fierlbeck W; Riess R; Geiger H
Med Klin (Munich); 1999 May; 94(5):274-8. PubMed ID: 10408189
[TBL] [Abstract][Full Text] [Related]
4. Myeloma and severe cholestasis.
Licht A; Maurer R; Oelz O
Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
[TBL] [Abstract][Full Text] [Related]
5. κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.
Oe Y; Nakaya I; Yahata M; Murata O; Yaegashi H; Sakuma T; Sato H; Liepnieks JJ; Benson MD; Soma J
Clin Nephrol; 2012 Jan; 77(1):66-70. PubMed ID: 22185971
[TBL] [Abstract][Full Text] [Related]
6. Vasotropic light-chain amyloidosis and ischaemic cholangiopathy.
Johnston EL; Wilkinson M; Knisely AS
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26113598
[TBL] [Abstract][Full Text] [Related]
7. Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma.
Terada T; Hirata K; Hisada Y; Hoshii Y; Nakanuma Y
Histopathology; 1994 May; 24(5):485-7. PubMed ID: 8088723
[TBL] [Abstract][Full Text] [Related]
8. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
[TBL] [Abstract][Full Text] [Related]
9. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
[TBL] [Abstract][Full Text] [Related]
10. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
[TBL] [Abstract][Full Text] [Related]
11. Primary amyloidosis presenting as intrahepatic cholestasis.
Bandyopadhyay SK; Bandyopadhyay R; Dutta A
Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
13. Cholestasis and renal failure in a patient with secondary amyloidosis.
Unsal C; Paydaş S; Gönlüşen G
Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
[TBL] [Abstract][Full Text] [Related]
14. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
Tzankov A; Pölzl G; Mairinger T
Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
[TBL] [Abstract][Full Text] [Related]
15. [Two autopsy cases with systemic amyloidosis--case 11/2010].
Schott S; Artunc F; Haap M; Mackensen-Haen S; Fend F; Riessen R
Dtsch Med Wochenschr; 2010 Nov; 135(44):2186. PubMed ID: 20979003
[TBL] [Abstract][Full Text] [Related]
16. Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL).
Yamamoto T; Maeda N; Kawasaki H
J Gastroenterol; 1995 Jun; 30(3):393-7. PubMed ID: 7647907
[TBL] [Abstract][Full Text] [Related]
17. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.
Faa G; Van Eyken P; De Vos R; Fevery J; Van Damme B; De Groote J; Desmet VJ
J Hepatol; 1991 Jan; 12(1):75-82. PubMed ID: 1901075
[TBL] [Abstract][Full Text] [Related]
18. Sarcoid, amyloid and heart failure.
Rakhit RD; Clesham GJ; Cleland JG
Int J Cardiol; 1993 Sep; 41(2):180-2. PubMed ID: 8282446
[TBL] [Abstract][Full Text] [Related]
19. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
[TBL] [Abstract][Full Text] [Related]
20. Massive systemic amyloidosis associated with light-chain deposition disease.
Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
